Savara SVRA
NASDAQ SVRA
$4.22 -0.32 (-7.05%)
At close: Oct 23, 2026 · 4:00 PM EDT

Savara (SVRA) Cash & Current Investments (2010 - 2026)

Updated

Savara's Cash & Current Investments was $173.03 million in Q2 2026, up 18.2% from $146.44 million a year earlier but down 14.7% from the prior quarter.

Analysis

Savara (SVRA) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Savara came in at $235.7 million, up 20.1% from FY2024.

  • Cash & Current Investments has now increased for three consecutive years, with a five-year compound annual growth rate of 23.5% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $196.33 million in FY2024 (+21.0%), $162.32 million in FY2023 (+29.0%), $125.88 million in FY2022 (-21.9%) and $161.17 million in FY2021 (+96.1%).
  • Quarterly Cash & Current Investments has moved between $105.18 million (Q2 2023) and $235.7 million (Q4 2025) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with growth averaging 13.1% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2021 (growth of 96.1%); the worst was Q3 2025 (a decline of 43.3%).
  • Per Business Quant data, SVRA's Cash & Current Investments in the three quarters before Q2 2026 was $202.8 million (Q1 2026), $235.7 million (Q4 2025) and $124.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Savara 866.79 Mn 130.84 Mn - 173.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 173.03 Mn
Mar 31, 2026 202.80 Mn
Dec 31, 2025 235.70 Mn
Sep 30, 2025 124.41 Mn
Jun 30, 2025 146.44 Mn
Mar 31, 2025 172.54 Mn
Dec 31, 2024 196.33 Mn
Sep 30, 2024 219.44 Mn
Jun 30, 2024 121.60 Mn
Mar 31, 2024 143.10 Mn
Dec 31, 2023 162.32 Mn
Sep 30, 2023 168.30 Mn
Jun 30, 2023 105.18 Mn
Mar 31, 2023 114.80 Mn
Dec 31, 2022 125.88 Mn
Sep 30, 2022 134.08 Mn
Jun 30, 2022 142.50 Mn
Mar 31, 2022 151.83 Mn
Dec 31, 2021 161.17 Mn
Sep 30, 2021 170.81 Mn
API Access

Savara Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SVRA&period=max&api_key=YOUR_API_KEY